| scholarly article | Q13442814 |
| P50 | author | Hilary Koprowski | Q936389 |
| P2093 | author name string | Steplewski Z | |
| Nilsson B | |||
| Zopf D | |||
| Brockhaus M | |||
| Ginsburg V | |||
| Magnani JL | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | monoclonal antibody | Q422248 |
| antibody | Q79460 | ||
| P304 | page(s) | 14365-14369 | |
| P577 | publication date | 1982-12-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II | |
| P478 | volume | 257 |
| Q30499157 | 5-Aza-2'-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating β-galactoside:α2,3-sialyltransferase 6 gene |
| Q33607940 | A Schistosoma mansoni epitope recognized by a protective monoclonal antibody is identical to the stage-specific embryonic antigen 1 |
| Q34610845 | A ganglioside antigen on the rat pancreatic B cell surface identified by monoclonal antibody R2D6. |
| Q36216733 | A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N-CAM. |
| Q68922113 | A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells. I. Immunohistological and immunochemical characterization of a murine monoclonal antibody selecting for well differentiated adenocarcinomas of the p |
| Q71635308 | A novel in vitro assay system for transendothelial tumor cell invasion: significance of E-selectin and alpha 3 integrin in the transendothelial invasion by HT1080 fibrosarcoma cells |
| Q36297916 | A standardized method for lectin microarray-based tissue glycome mapping |
| Q44247740 | A stomach oncofetal antigen recognized by monoclonal antibody GC302. |
| Q55014785 | Abnormal expression of blood group-related antigens in uterine endometrial cancers. |
| Q36126609 | Advances in biomarker research for pancreatic cancer |
| Q34635042 | Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. |
| Q67270035 | Altered expression of Lewis blood group and related antigens in fetal, normal adult and malignant tissues of the uterine endometrium |
| Q72681988 | An immunohistochemical employer monoclonal antibodies against Le(a), sialyl Le(a), Le(x), and sialyl Le(x) antigens in primary colorectal, carcinomas and lymph node and hepatic lesions |
| Q41506525 | Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant |
| Q67897414 | Analysis of the Lewisx epitope in human pancreas and pancreatic adenocarcinomas |
| Q68731523 | Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera |
| Q40280745 | Apoptosis of human breast carcinoma cells in the presence of cis-platin and L-/D-PPMP: IV. Modulation of replication complexes and glycolipid: Glycosyltransferases |
| Q30451103 | Binding of Actinomyces naeslundii to glycosphingolipids |
| Q34205596 | Biomarkers for Colorectal Cancer |
| Q53468067 | Blood group antigen expression in malignant tumors of the thyroid: a parallel between medullary and nonmedullary carcinomas. |
| Q37189924 | Blood group antigens A, B, H, Lea, Leb, and I(Ma) in resting and tetragastrin stimulated gastric juice of patients with non-neoplastic diseases of the stomach |
| Q41581022 | Blood group-active carbohydrate chains on the receptor for epidermal growth factor of A431 cells |
| Q36786361 | CA 19-9 and pancreatic cancer |
| Q37400577 | CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone |
| Q73024624 | CA 19-9 serum course and prognosis of pancreatic cancer |
| Q44578842 | CA 19-9 velocity predicts disease-free survival and overall survival after pancreatectomy of curative intent |
| Q24678824 | CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA |
| Q93012496 | CA19-9 for detecting recurrence of pancreatic cancer |
| Q35773128 | CA19-9-producing early gastric adenocarcinoma arising in hyperplastic foveolar polyp: a very unique resection case |
| Q41973331 | Cancer-associated tumour markers CA 19-9 and CA-50 in patients with pancreatic cancer with special reference to the Lewis blood cell status |
| Q48712442 | Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis |
| Q51549059 | Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases. |
| Q41532261 | Carbohydrate antigen expression in murine embryonic stem cells and embryos. II. Sialylated antigens and glycolipid analysis. |
| Q39850260 | Carbohydrate structure in tumor immunity |
| Q34129373 | Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases |
| Q92383411 | Challenges of Cholangiocarcinoma Detection in Patients with Primary Sclerosing Cholangitis |
| Q42164330 | Characterization of the binding epitope of a monoclonal antibody to sulphatide |
| Q71923167 | Chemical structure of the carbohydrate moiety of fucose-rich glycopeptides from human pancreatic juice |
| Q37010595 | Chemotherapy and immunotherapy of colorectal cancer |
| Q35046670 | Clinical significance and revisiting the meaning of CA 19-9 blood level before and after the treatment of pancreatic ductal adenocarcinoma: analysis of 1,446 patients from the pancreatic cancer cohort in a single institution |
| Q26828549 | Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis |
| Q68212805 | Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue |
| Q39993160 | Comparative study of CA242 and CA19-9 in chronic pancreatitis |
| Q69203343 | Comparative study on the expression of the blood group antigens Le a, Le b, Le x, Le y and the carbohydrate antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma |
| Q41761881 | Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases |
| Q42371644 | Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma |
| Q37785581 | Composition and production of pancreatic tumor related antigens |
| Q38638379 | Current status of tumor markers in large bowel cancer |
| Q35797487 | Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens |
| Q30444972 | Deletion of antigens of the Lewis a/b blood group family in human prostatic carcinoma |
| Q34548390 | Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma |
| Q50131377 | Development of quantitative immunochromatographic assay for rapid and sensitive detection of carbohydrate antigen 19-9 (CA 19-9) in human plasma |
| Q77620899 | Diagnostic value of CA 19-9 in patients with pancreatic cancer and nonspecific gastrointestinal symptoms |
| Q41892038 | Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma |
| Q72459645 | Different sialyltransferase activities in human colorectal carcinoma cells from surgical specimens detected by specific glycoprotein and glycolipid acceptors |
| Q37625192 | Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays |
| Q36214624 | Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins |
| Q33890583 | Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells |
| Q37190777 | Effect of neuraminidase on the expression of the 3-fucosyl-N-acetyllactosamine antigen in human tissues |
| Q72161397 | Elevation of ratio of urinary N-acetylneuraminlactose to free sialic acid in some advanced cancer patients |
| Q47810391 | Enzymatic Synthesis of N-Acetyllactosamine (LacNAc) Type 1 Oligomers and Characterization as Multivalent Galectin Ligands. |
| Q92063533 | Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology |
| Q41587869 | Establishment of a transplantable carcinoma arising from the intrahepatic bile duct in Syrian golden hamsters |
| Q41139337 | Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer |
| Q70155275 | Evaluation of CA19-9 serum levels for monitoring disease activity during chemotherapy of pancreatic adenocarcinoma |
| Q67859237 | Evaluation of CEA, CA 19-9, CA-50, CA-195, and TATI with special reference to pancreatic disorders |
| Q90222396 | Exploration of the Sialic Acid World |
| Q39543078 | Expression in normal adult, fetal, and neoplastic tissues of a carbohydrate differentiation antigen recognised by antigranulocyte mouse monoclonal antibodies |
| Q35831480 | Expression of alpha 2,6-linked sialic acid residues in neoplastic but not in normal human colonic mucosa. A lectin-gold cytochemical study with Sambucus nigra and Maackia amurensis lectins |
| Q41852370 | Expression of blood group antigens H-2, Le(y), and sialylated-Le(a) in human colorectal carcinoma. An immunohistochemical study using double-labeling techniques |
| Q44205217 | Expression of glycolipids bearing Lewis phenotypes in tissues and cultured cells of human gynecological cancers |
| Q42774313 | Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters. |
| Q72317046 | Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract |
| Q55115584 | Expression of sialylparagloboside in a case of liposarcoma: aberrant glycosylation in tumors arising in adipose tissues. |
| Q70296747 | Expression of the antigen detected by the monoclonal antibody Ca 19.9 in human breast tissues |
| Q68742947 | Factors affecting serum levels of CA 19-9 with special reference to benign hepatobiliary and pancreatic diseases |
| Q34498630 | Factors associated with serum CA19-9 levels among healthy children: a cross-sectional study |
| Q36213429 | Fate of tetanus toxin bound to the surface of primary neurons in culture: evidence for rapid internalization |
| Q41761118 | Flow cytometric analysis of sialyl Lewis A antigen on human cancer cells by using F(ab')2μ fragments prepared from a mouse IgM monoclonal antibody |
| Q37560614 | From carbohydrate leads to glycomimetic drugs |
| Q36050468 | Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients |
| Q45008557 | GD3 expression by cultured human tumor cells of neuroectodermal origin |
| Q37347955 | Ganglioside GM2 as a human tumor antigen (OFA-I-1) |
| Q42458115 | Ganglioside alterations in YAC-1 cells cultivated in serum-supplemented and serum-free growth medium |
| Q48619412 | Ganglioside expression in tissues of mice lacking beta2-microglobulin. |
| Q42127922 | Gastric Cancer with a Very High Serum CA 19-9 Level |
| Q41139267 | Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis |
| Q92542468 | Glycan Microarrays as Chemical Tools for Identifying Glycan Recognition by Immune Proteins |
| Q36340501 | Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodies |
| Q35583350 | Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A. |
| Q36687536 | Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9. |
| Q36742398 | Glycoprotein disease markers and single protein-omics |
| Q54219637 | Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography. |
| Q43465368 | Glycosphingolipids of human urothelial cell lines with different grades of transformation. |
| Q30454129 | Glycosyl-phosphatidylinositol/inositol phosphoglycan: a signaling system for the low-affinity nerve growth factor receptor |
| Q64912085 | Glycosylation in health and disease. |
| Q35818210 | Hepatocellular expression of a novel glycoprotein with sialylated difucosyl Lex activity in the active inflammatory lesions of chronic liver disease |
| Q44200019 | Human monoclonal IgM with autoantibody activity against two gangliosides (GM1 and GD1b) in a patient with motor neuron syndrome |
| Q40204757 | Human monoclonal antibodies: methods of production and some aspects of their application in oncology |
| Q36249946 | IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside |
| Q55398199 | Immunohistochemical expression of blood group substances and related carbohydrate antigens in breast carcinoma. |
| Q42515889 | Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A). |
| Q42840349 | Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9. |
| Q43860047 | Immunohistochemistry of human gastrointestinal cancer-associated antigen detected by monoclonal antibody PA 8-15. |
| Q37974938 | Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy |
| Q41594943 | In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands |
| Q36221729 | In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice |
| Q42840045 | Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin. |
| Q38354491 | Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue |
| Q42849648 | Interactions of soya-bean agglutinin with purified glycoconjugates and soya-bean seed components |
| Q37558378 | Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants |
| Q37678904 | Laminin binds specifically to sulfated glycolipids |
| Q28339099 | Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that r |
| Q33641713 | Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids |
| Q42738343 | Modulation of carbohydrate residues in regenerative nodules and neoplasms of canine and feline pancreas |
| Q35824027 | Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. |
| Q36213980 | Monoclonal antibodies as probes of epithelial membrane polarization |
| Q37508647 | Monoclonal antibodies in imaging and therapy of colorectal cancer |
| Q38352719 | Monoclonal antibodies recognizing epitopes carried on both glycolipids and glycoproteins of the human milk fat globule membrane |
| Q37691339 | Monoclonal antibody 18B8 detects gangliosides associated with neuronal differentiation and synapse formation |
| Q35858532 | Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues |
| Q41052960 | Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells. |
| Q54598905 | Murine monoclonal antibody recognizing human alpha(1,3/1,4)fucosyltransferase. |
| Q34161491 | Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides |
| Q94526998 | Nomogram using F-18 fluorodeoxyglucose positron emission tomography/computed tomography for preoperative prediction of lymph node metastasis in gastric cancer |
| Q67747126 | Normal colon of Sprague-Dawley rats. An immunohistochemical study |
| Q33187511 | Novel adapter protein AP162 connects a sialyl-Le(x)-positive mucin with an apoptotic signal transduction pathway |
| Q35831983 | Nuclear translocation of monoclonal antibody directed against cell-surface carbohydrate Y determinant |
| Q42160665 | Occurrence of a novel fucose-containing pentaglycosylceramide with blood-group-B active determinant in Xenopus blastula cells: its possible involvement in cell-cell adhesion |
| Q34171030 | P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer |
| Q74454093 | Papillary Thyroid Carcinoma Overexpresses Fully and Underglycosylated Mucins Together with Native and Sialylated Simple Mucin Antigens and Histo-Blood Group Antigens |
| Q34600819 | Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704 |
| Q35692128 | Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery. |
| Q55249052 | Production of monoclonal antibodies directed against carbohydrate moieties of cell surface glycoproteins. |
| Q45190269 | Prognostic Value of CA 19.9 Levels in Colorectal Cancer |
| Q40849316 | Protein glycosylation in cancer biology: an overview |
| Q43689455 | Purification and immunochemical characterization of ascitic fluid glycoproteins containing certain tumor-associated and blood group antigen markers |
| Q71368288 | Purification, properties, and immunological characterization of GalT-3 (UDP-galactose: GM2 ganglioside, beta 1-3 galactosyltransferase) from embryonic chicken brain |
| Q35423136 | Putative glycoprotein and glycolipid polymorphonuclear leukocyte receptors for the Actinomyces naeslundii WVU45 fimbrial lectin |
| Q55409136 | Recognition of the polypeptide core of mucin by monoclonal antibody MUSE11 against an adenocarcinoma-associated antigen. |
| Q37698104 | Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9. |
| Q43220035 | Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewis(b) blood group antigens in human colon by alpha-2-L-fucosylation |
| Q55309287 | Sandwich radioimmunometric assay with murine monoclonal antibody, NCC-ST-439, for serological diagnosis of human cancers. |
| Q35160719 | Scientific literature on monosialoganglioside in the Science Citation Index-Expanded: A bibliometric analysis of articles from 1942 to 2011 by each decade |
| Q67699692 | Serological and immunohistochemical studies on sialylated carbohydrate antigens in colorectal carcinoma |
| Q34379996 | Serum increase and liver overexpression of carbohydrate 19.9 antigen in patients with genetic haemochromatosis |
| Q34173603 | Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P-selectin |
| Q69847905 | Sialylated Lea blood group substances detected by the monoclonal antibody Ca 19-9 in human seminal plasma and other organs |
| Q41505109 | Significant inhibition of hybridoma cells by exogenous application of ganglioside GM3, a possible modulator of cell growth in vitro |
| Q35977794 | Similarity and co-expression of tumour-associated antigens recognised by different monoclonal antibodies |
| Q38366325 | Simple sugars to complex disease--mucin-type O-glycans in cancer |
| Q71671580 | Species-specific expression of sialosyl-Le(x) on polymorphonuclear leukocytes (PMN), in relation to selectin-dependent PMN responses |
| Q36559850 | Structure and function of glycosphingolipids and sphingolipids: recollections and future trends |
| Q41586276 | Sulfolipids and glycolipid sulfotransferase activities in human renal cell carcinoma cells |
| Q83261438 | Surface galactolipids of wheat protoplasts as receptors for soybean agglutinin and their possible relevance to host-parasite interaction |
| Q33768460 | Sweetening the pot: adding glycosylation to the biomarker discovery equation |
| Q33689062 | Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine |
| Q94602690 | Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic colorectal cancer |
| Q41779247 | The Gordon Wilson lecture. Monoclonal antibodies in human cancer |
| Q34290892 | The chemistry and immunochemistry of blood group A, B, H, and Lewis antigens: past, present and future |
| Q55061088 | The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies. |
| Q72700252 | The clinicopathologic features of serum CA 19-9-positive colorectal cancers |
| Q35794259 | The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities |
| Q35172546 | The emerging importance of α-L-fucose in human breast cancer: a review. |
| Q42373446 | The generation of monoclonal antibodies against human pancreatic exocrine cancer: a study of six different immunisation regimes |
| Q64227478 | The glycosylation landscape of pancreatic cancer |
| Q72152978 | The patterns of coexpression of tumor-associated antigens CA 19-9, TAG-72, and DU-PAN-2 in human pancreatic cancer |
| Q55380527 | The presence of CA19-9 in serum and saliva from Lewis blood-group negative cancer patients. |
| Q41819905 | The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer. |
| Q38349927 | The structural relationship of blood group-related oligosaccharides in human carcinoma to biological function: a perspective |
| Q34580285 | The sweet and sour of serological glycoprotein tumor biomarker quantification |
| Q73168409 | The usefulness of anti-fucosylated antigen antibody YB-2 for diagnosis of hepatocellular carcinoma |
| Q69653282 | Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma |
| Q43051293 | Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9. |
| Q37245533 | Towards an integrated proteomic and glycomic approach to finding cancer biomarkers |
| Q51836026 | Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions. |
| Q37485741 | Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells |
| Q36264719 | Tumour markers: An overview |
| Q72064034 | Type-1 chain histo-blood group antigens (Le(a), monosialosyl-Le(a), disialosyl-Le(a), Le(b), and H) in normal and malignant human endometrium |
| Q53817138 | Very high serum CA 19-9 levels: a contraindication to pancreaticoduodenectomy? |
| Q34446989 | Wisteria floribunda agglutinin-binding glycan expression is decreased in endometriomata |
| Q71123116 | [Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens] |
| Q73506534 | [Clinical value of the CA 19-9 tumor marker with special reference to the Lewis phenotype] |
| Q33720541 | α3/4 Fucosyltransferase 3-dependent synthesis of Sialyl Lewis A on CD44 variant containing exon 6 mediates polymorphonuclear leukocyte detachment from intestinal epithelium during transepithelial migration |
Search more.